Seaport Therapeutics Reports Second Quarter 2026 Results, Highlights Positive Clinical Progress and Strengthened Financial Position Following IPO Seaport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for neuropsychiatric disorders, has announced its financial results for the second…
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into a strategic research collaboration with Rio Biofarma Brasil Ltda. (RBBL),…
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid medicines for pain management, has announced the publication of positive…
Virta Health Study Suggests Nutrition-Based Metabolic Care May Significantly Reduce Risk of Chronic Kidney Disease Virta Health, a leader in reversing metabolic disease through individualized nutrition-based care, has announced the publication of a major peer-reviewed study demonstrating that chronic kidney…
Shionogi Launches XOCOVA® in the United States as the First Oral Post-Exposure COVID-19 Prevention Therapy Shionogi Inc., the U.S. subsidiary of Japan-based pharmaceutical company Shionogi & Co., Ltd., has announced the commercial availability of XOCOVA® (ensitrelvir) in the United States…
bioAffinity Technologies Publishes Clinical White Paper Highlighting Practical Use of CyPath® Lung for Pulmonary Nodule Risk Assessment bioAffinity Technologies, Inc., a biotechnology company dedicated to advancing noninvasive diagnostics and early cancer detection, has announced the publication of a comprehensive clinical…
Arcus Biosciences and Summit Therapeutics Collaborate to Advance Novel Combination Therapy for Advanced Kidney Cancer Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative therapies for cancer as well as inflammatory and autoimmune diseases, has entered into…
Kairos Pharma and Bayer Partner to Advance Combination Therapy for Metastatic Prostate Cancer Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing therapies that overcome cancer drug resistance, has announced a strategic research collaboration with Bayer to evaluate its…
bioAffinity Technologies and Pictor Partner to Advance Next-Generation Precision Diagnostics for Asthma and COPD bioAffinity Technologies, Inc., a biotechnology company focused on developing innovative cancer diagnostics and targeted therapeutics, has announced a strategic collaboration with Pictor®, Inc., a company specializing…
The BRAIN Foundation and Stanford Medicine Launch Aurora Research Network to Advance Evidence-Based Care for Severe Neuropsychiatric Deterioration The BRAIN Foundation, in partnership with Stanford Medicine, has announced the launch of the Aurora Research Network (ARN), a nationwide collaborative initiative…
Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 Gene-Edited Cell Therapy for Friedreich’s Ataxia Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) dedicated to advancing cell therapy manufacturing, has announced a strategic collaboration with Papillon Therapeutics…
Ashlins Pharmaceuticals Signs Exclusive Global Licensing Agreement with Lee’s Pharmaceutical Holdings to Advance Interferon Alpha-2b Drug Development Ashlins Pharmaceuticals has announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc., has entered into an exclusive license and supply agreement with…